Spots Global Cancer Trial Database for total mesorectal excision
Every month we try and update this database with for total mesorectal excision cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen | NCT04340401 | Rectal Cancer | SHR-1210 Oxaliplatin Capecitabine Intensity modul... Total mesorecta... | 18 Years - 70 Years | Peking University Cancer Hospital & Institute | |
Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer | NCT04703101 | Locally Advance... Rectal Adenocar... Stage II Rectal... Stage IIA Recta... Stage IIB Recta... Stage IIC Recta... Stage III Recta... Stage IIIA Rect... Stage IIIB Rect... Stage IIIC Rect... | Capecitabine Fluorouracil Intensity-Modul... Leucovorin Oxaliplatin Quality-of-Life... Surveillance Total Mesorecta... | 18 Years - | Jonsson Comprehensive Cancer Center | |
Local Excision for Organ Preservation in Early REctal Cancer With No Adjuvant Treatment | NCT05927584 | Rectal Cancer Rectum Neoplasm | Transanal local... | 18 Years - | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | |
PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer | NCT04301557 | DMMR Colorectal... MSI-H Colorecta... Locally Advance... | PD-1 Antibody Oxaliplatin Capecitabine External beam r... Total mesorecta... | 18 Years - 72 Years | Sun Yat-sen University | |
Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen | NCT04340401 | Rectal Cancer | SHR-1210 Oxaliplatin Capecitabine Intensity modul... Total mesorecta... | 18 Years - 70 Years | Peking University Cancer Hospital & Institute | |
THREE-row Circular STAPLER in Low Anterior Resection for Rectal Cancer | NCT03910699 | Anastomotic Lea... Anastomotic Hae... Anastomotic Com... Rectal Neoplasm... Staple Misfire Anastomosis Anastomotic Ste... | Three-row circu... Two-row circula... | 18 Years - 85 Years | Russian Society of Colorectal Surgeons | |
Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in T2-T3s N0, M0 Rectal Cancer | NCT01308190 | Rectal Cancer | Capecitabine (X... 50.4 Gy Transanal Endos... Total Mesorecta... | 18 Years - | Corporacion Parc Tauli | |
MRI Split Scar Sign as a Predictor to Complete Pathologic Response After Neoadjuvant Chemoradiation in Rectal Cancer | NCT04745091 | Rectum Cancer | total mesorecta... | - | Alexandria University | |
PROSPECTIVE CONTROLLED AND RANDOMIZED STUDY OF THE GENITOURINARY FUNCTION AFTER RECTAL CANCER SURGERY IN RELATION TO THE DISSECTION OF THE INFERIOR MESENTERIC VESSELS | NCT03520088 | Rectal Cancer | Inferior mesent... Inferior mesent... | 18 Years - 100 Years | Corporacion Parc Tauli | |
Induction Chemotherapy for MRF-negative, Moderate-risk, Resectable Middle and Low Rectal Cancer | NCT04296240 | Rectal Cancer | Oxaliplatin and... Total Mesorecta... | 18 Years - 80 Years | Peking University Cancer Hospital & Institute | |
Timing Evaluation of Stoma Closure (TIMES). Early vs Late Closure of Stoma After Rectal Cancer Surgery. | NCT05284864 | Rectal Cancer Total Mesorecta... Ileostomy - Sto... Ileostomy; Comp... Ileostomy Closu... | Stoma closure | 18 Years - | Hospital Universitario La Fe | |
The Efficacy of Primary Total Mesorectal Excision (TME) Surgery Versus Neoadjuvant Chemotherapy Combined With TME Surgery in Low-risk Locally Advanced Rectal Cancer | NCT05984485 | Rectal Cancer | neoadjuvant che... total mesorecta... | 18 Years - 75 Years | Sun Yat-sen University | |
Laparoscopic Assisted Transanal Total Mesorectal Excision for Rectal Cancer in Low Site | NCT03253302 | Rectal Cancer | 18 Years - 80 Years | Beijing Friendship Hospital | ||
Transanal Versus Laparoscopic Total Mesorectal Excision For Rectal Cancer | NCT02966483 | Rectal Neoplasm... Surgery | TaTME LpTME | 18 Years - 75 Years | Sun Yat-sen University | |
Minimally Invasive Sphincter Sparing Total Mesorectal Excision for Ultra-low Rectal Cancer After Initial Chemo-radiotherapy (MISS-TRICR). | NCT02488707 | Rectal Cancer | laparoscopic in... Transanal minim... | 18 Years - | Mansoura University | |
MRI Simulation-guided Boost in Short-course Preoperative Radiotherapy for Unresectable Rectal Cancer | NCT03714490 | Rectal Neoplasm... | SCPRT CRT CAPOX | 18 Years - 70 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
Transanal Versus Laparoscopic Total Mesorectal Excision For Rectal Cancer | NCT02966483 | Rectal Neoplasm... Surgery | TaTME LpTME | 18 Years - 75 Years | Sun Yat-sen University | |
RATME vs LATME in Middle and Low Rectal Cancer | NCT06105203 | Total Mesorecta... Rectal Neoplasm... Robotic Surgica... Laparoscopy | Robotic-assiste... laparoscopic-as... | 18 Years - 75 Years | The First Hospital of Jilin University | |
Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer | NCT02864849 | Rectal Cancer | Oxaliplatin Capecitabine Intensity modul... Total mesorecta... | 18 Years - 75 Years | Peking University Cancer Hospital & Institute | |
Induction Chemotherapy for MRF-negative, Moderate-risk, Resectable Middle and Low Rectal Cancer | NCT04296240 | Rectal Cancer | Oxaliplatin and... Total Mesorecta... | 18 Years - 80 Years | Peking University Cancer Hospital & Institute | |
Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer | NCT04703101 | Locally Advance... Rectal Adenocar... Stage II Rectal... Stage IIA Recta... Stage IIB Recta... Stage IIC Recta... Stage III Recta... Stage IIIA Rect... Stage IIIB Rect... Stage IIIC Rect... | Capecitabine Fluorouracil Intensity-Modul... Leucovorin Oxaliplatin Quality-of-Life... Surveillance Total Mesorecta... | 18 Years - | Jonsson Comprehensive Cancer Center | |
Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in T2-T3s N0, M0 Rectal Cancer | NCT01308190 | Rectal Cancer | Capecitabine (X... 50.4 Gy Transanal Endos... Total Mesorecta... | 18 Years - | Corporacion Parc Tauli | |
Local Excision Versus Total Mesorectal Excision In Pathological Complete Response (ypT0-1cN0) Mid- Or Low-Rectal Cancer After Neoadjuvant Therapy | NCT03548844 | Rectal Cancer Surgery | local excision total mesorecta... | 18 Years - 75 Years | Sun Yat-sen University | |
Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma | NCT01302613 | Stage II Rectal... Stage III Recta... | Capecitabine 5-FU Leucovorin Oxaliplatin radiation total mesorecta... | 18 Years - | University of Texas Southwestern Medical Center | |
Pd1 Antibody Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal Cancer | NCT04304209 | Colorectal Canc... Colorectal Canc... | Oxaliplatin Capecitabine Sintilimab radiotherapy total mesorecta... Watch and wait | 18 Years - 75 Years | Sun Yat-sen University | |
Total Neoadjuvant Therapy Followed by 'Watch and Wait' Approach or Organ Preservation for Low-risk Rectal Cancer | NCT04405206 | Rectum Cancer | Oxaliplatin Capecitabine intensity modul... DRE-Endoscopy-M... Nonoperative Ma... Local excision Total Mesorecta... Quality of Life... | 18 Years - 85 Years | Peking University Cancer Hospital & Institute | |
Local Excision Versus Total Mesorectal Excision In Pathological Complete Response (ypT0-1cN0) Mid- Or Low-Rectal Cancer After Neoadjuvant Therapy | NCT03548844 | Rectal Cancer Surgery | local excision total mesorecta... | 18 Years - 75 Years | Sun Yat-sen University | |
The Efficacy of Penile Rehabilitation Using Udenafil After Total Mesorectal Excision of Rectal Cancer | NCT01421940 | Rectal Cancer | Placebo drug Udenafil | 20 Years - 65 Years | Kyungpook National University Hospital | |
MRI Features in Neoadjuvant Treatment Decisions for Patients With Rectal Cancer | NCT05609149 | Rectal Cancer | total mesorecta... | 18 Years - 80 Years | Sun Yat-sen University | |
The Efficacy of Penile Rehabilitation Using Udenafil After Total Mesorectal Excision of Rectal Cancer | NCT01421940 | Rectal Cancer | Placebo drug Udenafil | 20 Years - 65 Years | Kyungpook National University Hospital | |
RATME vs LATME in Middle and Low Rectal Cancer | NCT06105203 | Total Mesorecta... Rectal Neoplasm... Robotic Surgica... Laparoscopy | Robotic-assiste... laparoscopic-as... | 18 Years - 75 Years | The First Hospital of Jilin University | |
Transanal Transection and Single-stapled Anastomosis (TTSS) in Rectal Cancer Patients | NCT06314646 | Rectal Cancer Surgery | Transanal Trans... Double-stapled ... | 18 Years - | Istituto Clinico Humanitas | |
Local Excision in Downstaged Rectal Cancer | NCT00427375 | Rectal Neoplasm... | local rectal ex... total mesorecta... | 18 Years - | University Hospital, Bordeaux | |
Multicenter Study on Postoperative Urinary and Sexual Function During Laparoscopic Functional Total Mesorectum Excision | NCT05049317 | Rectal Cancer | Laparoscopic FT... | 18 Years - 70 Years | Renmin Hospital of Wuhan University | |
Induction Chemotherapy for MRF-negative, Moderate-risk, Resectable Middle and Low Rectal Cancer | NCT04296240 | Rectal Cancer | Oxaliplatin and... Total Mesorecta... | 18 Years - 80 Years | Peking University Cancer Hospital & Institute | |
Abdominoperineal Extra-Elevators Rectal Resection for Cancer: Prone Position vs. Supine Position | NCT02163785 | Rectal Cancer Abdominoperinea... | Abdominoperinea... | 18 Years - | Hospital Universitario La Fe | |
Robotic vs. TaTME Rectal Surgery (ROTA STUDY) | NCT04200027 | Rectal Cancer | total mesorecta... | 18 Years - | Odense University Hospital | |
Optimization of Preoperative Treatment in Locally Advanced Rectal Cancer | NCT02533271 | Cancer, Rectum | Short-course ra... Long-term chemo... | 18 Years - 70 Years | ChineseAMS | |
Total Neoadjuvant Therapy Followed by 'Watch and Wait' Approach or Organ Preservation for Low-risk Rectal Cancer | NCT04405206 | Rectum Cancer | Oxaliplatin Capecitabine intensity modul... DRE-Endoscopy-M... Nonoperative Ma... Local excision Total Mesorecta... Quality of Life... | 18 Years - 85 Years | Peking University Cancer Hospital & Institute | |
Surgery Alone Versus Neoadjuvant Treatment Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer | NCT05496270 | Rectal Cancer | total mesorecta... | 18 Years - 80 Years | Sun Yat-sen University | |
Early-onset Rectal Cancer | NCT04496765 | Rectal Cancer | Total mesorecta... | 10 Years - 80 Years | Mansoura University | |
Lateral Lymph Node Dissection After Neoadjuvant Chemo-radiation in Advanced Low Rectal Cancer | NCT02614157 | Rectal Cancer | LLND labeled line | 18 Years - 75 Years | West China Hospital | |
Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen | NCT04340401 | Rectal Cancer | SHR-1210 Oxaliplatin Capecitabine Intensity modul... Total mesorecta... | 18 Years - 70 Years | Peking University Cancer Hospital & Institute | |
A Study on the Efficacy of a Novel Approach to Achieving Laparoscopic Distal Rectal Transection for Rectal Cancers | NCT05067413 | Rectal Neoplasm... | Transanterior o... Total mesorecta... | 18 Years - 80 Years | Peking University First Hospital | |
Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma | NCT03503630 | Locally Advance... | COMPOUND 205526... Radiation Thera... mFOLFOX Total Mesorecta... | 18 Years - | American University of Beirut Medical Center | |
Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer | NCT04751370 | Locally Advance... Stage II Rectal... Stage III Recta... | Computed Tomogr... Ipilimumab Magnetic Resona... Nivolumab Radiation Thera... Sigmoidoscopy Total Mesorecta... | 18 Years - | National Cancer Institute (NCI) | |
Introduction and Influence of Total Mesorectal Excision (TME) in the Treatment of Rectal Cancer | NCT00910143 | Rectal Cancer | conventional re... total mesorecta... | 16 Years - | Insel Gruppe AG, University Hospital Bern | |
Machine Learning-based Surgical Guidance System for Robot-assisted Rectal Surgery | NCT05652361 | Rectum Cancer | Additional visu... | 18 Years - | Technische Universität Dresden | |
Surgery Alone Versus Neoadjuvant Treatment Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer | NCT05496270 | Rectal Cancer | total mesorecta... | 18 Years - 80 Years | Sun Yat-sen University | |
Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer | NCT04751370 | Locally Advance... Stage II Rectal... Stage III Recta... | Computed Tomogr... Ipilimumab Magnetic Resona... Nivolumab Radiation Thera... Sigmoidoscopy Total Mesorecta... | 18 Years - | National Cancer Institute (NCI) | |
Lateral Lymph Node Dissection After Neoadjuvant Chemo-radiation in Advanced Low Rectal Cancer | NCT02614157 | Rectal Cancer | LLND labeled line | 18 Years - 75 Years | West China Hospital | |
A Study on the Efficacy of a Novel Approach to Achieving Laparoscopic Distal Rectal Transection for Rectal Cancers | NCT05067413 | Rectal Neoplasm... | Transanterior o... Total mesorecta... | 18 Years - 80 Years | Peking University First Hospital | |
The Efficacy of Penile Rehabilitation Using Udenafil After Total Mesorectal Excision of Rectal Cancer | NCT01421940 | Rectal Cancer | Placebo drug Udenafil | 20 Years - 65 Years | Kyungpook National University Hospital | |
Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer | NCT04703101 | Locally Advance... Rectal Adenocar... Stage II Rectal... Stage IIA Recta... Stage IIB Recta... Stage IIC Recta... Stage III Recta... Stage IIIA Rect... Stage IIIB Rect... Stage IIIC Rect... | Capecitabine Fluorouracil Intensity-Modul... Leucovorin Oxaliplatin Quality-of-Life... Surveillance Total Mesorecta... | 18 Years - | Jonsson Comprehensive Cancer Center | |
Multicenter Phase II Study of Transanal TME (taTME) | NCT03144765 | Rectal Cancer Surgery | Transanal Total... | 18 Years - | Icahn School of Medicine at Mount Sinai | |
Local Excision in Downstaged Rectal Cancer | NCT00427375 | Rectal Neoplasm... | local rectal ex... total mesorecta... | 18 Years - | University Hospital, Bordeaux | |
Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management | NCT02008656 | Rectal Cancer | Oxaliplatin (OX... 5-Fluorouracil ... Leucovorin Capecitabine (X... intensity modul... Quality of Life... DRE-Endoscopy | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma | NCT03503630 | Locally Advance... | COMPOUND 205526... Radiation Thera... mFOLFOX Total Mesorecta... | 18 Years - | American University of Beirut Medical Center | |
Introduction and Influence of Total Mesorectal Excision (TME) in the Treatment of Rectal Cancer | NCT00910143 | Rectal Cancer | conventional re... total mesorecta... | 16 Years - | Insel Gruppe AG, University Hospital Bern | |
Machine Learning-based Surgical Guidance System for Robot-assisted Rectal Surgery | NCT05652361 | Rectum Cancer | Additional visu... | 18 Years - | Technische Universität Dresden | |
Rectal Surgery Evaluation Trial (RESET) | NCT03574493 | Rectal Cancer | TME with LAR | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
Transanal Versus Laparoscopic Total Mesorectal Excision For Rectal Cancer | NCT03359616 | Rectal Cancer Surgery | Transanally cur... Laparoscopic to... | 18 Years - 75 Years | Shanghai Minimally Invasive Surgery Center | |
Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma | NCT01302613 | Stage II Rectal... Stage III Recta... | Capecitabine 5-FU Leucovorin Oxaliplatin radiation total mesorecta... | 18 Years - | University of Texas Southwestern Medical Center | |
Intraoperative Monitoring of the Pelvic Autonomic Nerves | NCT01585727 | Rectal Cancer | TME TME Neuromonitoring | 18 Years - 90 Years | Johannes Gutenberg University Mainz | |
Efficacy and Safety of SCRT Versus TNT in Older Patients With Locally Advanced Rectal Cancer | NCT06052332 | Locally Advance... Older People | Short course ra... Adjuvant chemot... Total mesorecta... Total neoadjuva... | 70 Years - | Jules Bordet Institute |